These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17997086)
21. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan. Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666 [TBL] [Abstract][Full Text] [Related]
22. Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Hartman O; Zhang C; Adams EL; Farach-Carson MC; Petrelli NJ; Chase BD; Rabolt JF Biomaterials; 2010 Jul; 31(21):5700-18. PubMed ID: 20417554 [TBL] [Abstract][Full Text] [Related]
23. Cooperation between thrombospondin-1 type 1 repeat peptides and alpha(v)beta(3) integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation. Sipes JM; Krutzsch HC; Lawler J; Roberts DD J Biol Chem; 1999 Aug; 274(32):22755-62. PubMed ID: 10428859 [TBL] [Abstract][Full Text] [Related]
24. C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase. Kim J; Han I; Kim Y; Kim S; Oh ES Biochem J; 2001 Nov; 360(Pt 1):239-45. PubMed ID: 11696013 [TBL] [Abstract][Full Text] [Related]
25. Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan. Kvansakul M; Hopf M; Ries A; Timpl R; Hohenester E EMBO J; 2001 Oct; 20(19):5342-6. PubMed ID: 11574465 [TBL] [Abstract][Full Text] [Related]
26. Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation. Sher I; Zisman-Rozen S; Eliahu L; Whitelock JM; Maas-Szabowski N; Yamada Y; Breitkreutz D; Fusenig NE; Arikawa-Hirasawa E; Iozzo RV; Bergman R; Ron D J Biol Chem; 2006 Feb; 281(8):5178-87. PubMed ID: 16269412 [TBL] [Abstract][Full Text] [Related]
27. A unique sequence of the laminin alpha 3 G domain binds to heparin and promotes cell adhesion through syndecan-2 and -4. Utani A; Nomizu M; Matsuura H; Kato K; Kobayashi T; Takeda U; Aota S; Nielsen PK; Shinkai H J Biol Chem; 2001 Aug; 276(31):28779-88. PubMed ID: 11373281 [TBL] [Abstract][Full Text] [Related]
28. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. French MM; Gomes RR; Timpl R; Höök M; Czymmek K; Farach-Carson MC; Carson DD J Bone Miner Res; 2002 Jan; 17(1):48-55. PubMed ID: 11771669 [TBL] [Abstract][Full Text] [Related]
29. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. Chakravarti S; Horchar T; Jefferson B; Laurie GW; Hassell JR J Biol Chem; 1995 Jan; 270(1):404-9. PubMed ID: 7814401 [TBL] [Abstract][Full Text] [Related]
30. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation. Pasco S; Monboisse JC; Kieffer N J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203 [TBL] [Abstract][Full Text] [Related]
31. Screening of integrin-binding peptides from the laminin α4 and α5 chain G domain peptide library. Katagiri F; Ishikawa M; Yamada Y; Hozumi K; Kikkawa Y; Nomizu M Arch Biochem Biophys; 2012 May; 521(1-2):32-42. PubMed ID: 22391228 [TBL] [Abstract][Full Text] [Related]
32. Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin. Huebsch JC; McCarthy JB; Diglio CA; Mooradian DL Circ Res; 1995 Jul; 77(1):43-53. PubMed ID: 7788881 [TBL] [Abstract][Full Text] [Related]
33. Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3. Erdman R; Stahl RC; Rothblum K; Chernousov MA; Carey DJ J Biol Chem; 2002 Mar; 277(9):7619-25. PubMed ID: 11751872 [TBL] [Abstract][Full Text] [Related]
34. The integrin beta1 subunit transmembrane domain regulates phosphatidylinositol 3-kinase-dependent tyrosine phosphorylation of Crk-associated substrate. Armulik A; Velling T; Johansson S Mol Biol Cell; 2004 Jun; 15(6):2558-67. PubMed ID: 15034138 [TBL] [Abstract][Full Text] [Related]
35. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1. Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861 [TBL] [Abstract][Full Text] [Related]
36. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate. Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923 [TBL] [Abstract][Full Text] [Related]
37. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695 [TBL] [Abstract][Full Text] [Related]
38. TGF-β enhances deposition of perlecan from COPD airway smooth muscle. Ichimaru Y; Krimmer DI; Burgess JK; Black JL; Oliver BG Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L325-33. PubMed ID: 22003087 [TBL] [Abstract][Full Text] [Related]
39. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. Hopf M; Göhring W; Mann K; Timpl R J Mol Biol; 2001 Aug; 311(3):529-41. PubMed ID: 11493006 [TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. Mongiat M; Otto J; Oldershaw R; Ferrer F; Sato JD; Iozzo RV J Biol Chem; 2001 Mar; 276(13):10263-71. PubMed ID: 11148217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]